Reportlinker Adds The Asthma, COPD & Allergic Rhinitis Market Outlook to 2016 – Centre Daily Times

Reportlinker Adds The Asthma, COPD & Allergic Rhinitis Market Outlook to 2016
Centre Daily Times
The global respiratory market was valued at $44.0bn in sales in 2010 with asthma/COPD drugs being the key revenue drivers of the therapeutic segment. Of respiratory indications, asthma represents the main area of R&D interest for pharmaceutical

and more »

View full post on asthma – Google News

Reportlinker Adds The Asthma, COPD & Allergic Rhinitis Market Outlook to 2016 – SYS-CON Media (press release)

Reportlinker Adds The Asthma, COPD & Allergic Rhinitis Market Outlook to 2016
SYS-CON Media (press release)
The global respiratory market was valued at $44.0bn in sales in 2010 with asthma/COPD drugs being the key revenue drivers of the therapeutic segment. Of respiratory indications, asthma represents the main area of R&D interest for pharmaceutical

and more »

View full post on asthma – Google News